Login / Signup

Evolving treatment strategies in CML - moving from early and deep molecular responses to TKI discontinuation and treatment-free remission: is there a need for longer-term trial outcomes?

Ahmet Emre Eskazan
Published in: British journal of clinical pharmacology (2018)
Keyphrases